. .. Remerciements,

. .. Serment-d'hippocrate,

.. .. Le-cancer-de-l'endomètre,

. .. Epidémiologie,

.. .. Histoire-naturelle,

. .. Facteurs-de-risque,

. .. Circonstances-de-découverte,

.. .. Bilan-initial-et-d'extension,

. .. Bilan-pré-thérapeutique,

. .. Sous-groupes-moléculaires,

.. .. Principes,

. .. Pronostic,

.. .. Les-marqueurs-de-prolifération,

. , 31 La protéine MCM6 (MiniChromosome Maintenance protein 6)

. .. Objectifs,

. .. Développement-du-sujet,

. .. Title,

.. .. Authors,

.. .. Corresponding,

. .. Abstract,

.. .. Key-words,

. Materials and . .. Methods,

. .. Ethics,

. .. Immunohistochemistry,

. .. Results, 45 MCM6 and Ki-67 protein expressions in endometrial adenocarcinoma

. , 47 Prognostic value of levels of Ki-67 and MCM6 mRNA in TCGA database and correlation with molecular features

. .. Discussion, 49 Clinico-pathological prognostic factors in endometrioid type endometrial neoplasm

. , CENP-A containing chromatin organization (p=2.48E-9, pp.94-105

R. L. Siegel, K. D. Miller, and A. Jemal, Cancer statistics, CA Cancer J Clin, vol.66, pp.7-30, 2016.

J. Ferlay, E. Steliarova-foucher, and J. Lortet-tieulent, Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012, Eur J Cancer Oxf Engl, vol.49, pp.1374-1403, 1990.

G. F. Fleming, V. L. Brunetto, and D. Cella, Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study, J Clin Oncol Off J Am Soc Clin Oncol, vol.22, pp.2159-2166, 2004.

J. T. Thigpen, M. F. Brady, and H. D. Homesley, Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a gynecologic oncology group study, 2004.

, J Clin Oncol Off J Am Soc Clin Oncol, vol.22, pp.3902-3908

E. Petru, H. Lück, and G. Stuart, Gynecologic Cancer Intergroup (GCIG) proposals for changes of the current FIGO staging system, Eur J Obstet Gynecol Reprod Biol, vol.143, pp.69-74, 2009.

H. B. Salvesen, O. E. Iversen, and L. A. Akslen, Identification of high-risk patients by assessment of nuclear Ki-67 expression in a prospective study of endometrial carcinomas, Clin Cancer Res Off J Am Assoc Cancer Res, vol.4, pp.2779-2785, 1998.

P. Romanowski and M. A. Madine, Mechanisms restricting DNA replication to once per cell cycle: the role of Cdc6p and ORC, Trends Cell Biol, vol.7, pp.9-10, 1997.

C. Vigouroux, J. Casse, and S. Battaglia-hsu, Methyl(R217)HuR and MCM6 are inversely correlated and are prognostic markers in non small cell lung carcinoma, Lung Cancer Amst Neth, vol.89, pp.189-196, 2015.

G. Gauchotte, C. Vigouroux, and F. Rech, Expression of minichromosome maintenance MCM6 protein in meningiomas is strongly correlated with histologic grade and clinical outcome, Am J Surg Pathol, vol.36, pp.283-291, 2012.

K. Kato, T. Toki, and M. Shimizu, Expression of replication-licensing factors MCM2 and MCM3 in normal, hyperplastic, and carcinomatous endometrium: correlation with expression of Ki-67 and estrogen and progesterone receptors, Int J Gynecol Pathol Off J Int Soc Gynecol Pathol, vol.22, pp.334-340, 2003.

S. S. Li, W. C. Xue, and U. S. Khoo, Replicative MCM7 protein as a proliferation marker in endometrial carcinoma: a tissue microarray and clinicopathological analysis, Gynecol Obstet Invest, vol.46, pp.307-313, 2005.

N. Colombo, C. Creutzberg, and F. Amant, ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-up, Int J Gynecol Cancer Off J Int Gynecol Cancer Soc, vol.26, 2016.

L. Ouldamer, S. Bendifallah, and G. Body, Call for Surgical Nodal Staging in Women with ESMO/ESGO/ESTRO High-Intermediate Risk Endometrial Cancer: A Multicentre Cohort Analysis from the FRANCOGYN Study Group, Ann Surg Oncol, vol.24, pp.1660-1666, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01543368

A. Alkushi, P. Lim, and A. Coldman, Interpretation of p53 immunoreactivity in endometrial carcinoma: establishing a clinically relevant cut-off level, Int J Gynecol Pathol Off J Int Soc Gynecol Pathol, vol.23, pp.129-137, 2004.

T. Alvarez, E. Miller, L. Duska, and E. Oliva, Molecular profile of grade 3 endometrioid endometrial carcinoma: is it a type I or type II endometrial carcinoma?, Am J Surg Pathol, vol.36, pp.753-761, 2012.

, Int J Gynecol Pathol Off J Int Soc Gynecol Pathol, vol.22, pp.141-148

B. Djordjevic, B. A. Barkoh, R. Luthra, and R. R. Broaddus, Relationship between PTEN, DNA mismatch repair, and tumor histotype in endometrial carcinoma: retained positive expression of PTEN preferentially identifies sporadic non, 2013.

, Mod Pathol Off J U S Can Acad Pathol Inc, vol.26, pp.1401-1412

A. J. Levine, J. Momand, and C. A. Finlay, The p53 tumour suppressor gene, Nature, vol.351, pp.453-456, 1991.

A. M. Schultheis, L. G. Martelotto, D. Filippo, and M. R. , TP53 Mutational Spectrum in Endometrioid and Serous Endometrial Cancers, Int J Gynecol Pathol Off J Int Soc Gynecol Pathol, vol.35, pp.289-300, 2016.

M. F. Kohler, P. Carney, and R. Dodge, p53 overexpression in advanced-stage endometrial adenocarcinoma, Am J Obstet Gynecol, vol.175, pp.1246-1252, 1996.

P. Kohlberger, G. Gitsch, and A. Loesch, ) p53 protein overexpression in early stage endometrial cancer, Gynecol Oncol, vol.62, pp.213-217, 1996.

S. Ozalp, O. T. Yalcin, and H. M. Tanir, overexpression as a prognostic indicator in endometrial carcinoma, Eur J Gynaecol Oncol, vol.24, pp.275-278, 2003.

M. Kudela, R. Pilka, and M. Lubusky, Prognostic importance of selected molecular immunohistochemical markers and DNA ploidy in endometrial cancer, Eur J Gynaecol Oncol, vol.33, pp.159-163, 2012.

M. Miyaki, M. Konishi, and K. Tanaka, Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer, Nat Genet, vol.17, pp.271-272, 1997.

N. C. Nicolaides, N. Papadopoulos, and B. Liu, Mutations of two PMS homologues in hereditary nonpolyposis colon cancer, Nature, vol.371, pp.75-80, 1994.

H. J. An, K. I. Kim, and J. Y. Kim, Microsatellite instability in endometrioid type endometrial adenocarcinoma is associated with poor prognostic indicators, Am J Surg Pathol, vol.31, pp.309-314, 2007.

. Bibliographie,

J. Ferlay, E. Steliarova-foucher, J. Lortet-tieulent, S. Rosso, J. Coebergh et al., Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012, Eur J Cancer Oxf Engl, vol.49, issue.6, pp.1374-403, 1990.

S. R. Bayer and A. H. Decherney, Clinical manifestations and treatment of dysfunctional uterine bleeding, JAMA, vol.269, issue.14, pp.1823-1831, 1993.

R. L. Siegel, K. D. Miller, and A. Jemal, Cancer statistics, CA Cancer J Clin, vol.66, issue.1, pp.7-30, 2016.

N. Leone, N. Voirin, L. Roche, F. Binder-foucard, A. Woronoff et al., Projection de l'incidence et de la mortalité par cancer en France métropolitaine en 2015, 2015.

W. T. Creasman, F. Odicino, P. Maisonneuve, M. A. Quinn, U. Beller et al., Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer, Int J Gynaecol Obstet Off Organ Int Fed Gynaecol Obstet, vol.95, issue.1, pp.105-148, 2006.

M. Ballester, G. Canlorbe, A. Cortez, J. Gonin, E. Laas et al., Histological and immunohistochemical profiles predict lymph node status in women with lowintermediate risk endometrial cancer, Gynecol Oncol, vol.130, issue.3, pp.457-62, 2013.

G. Canlorbe, E. Laas, S. Bendifallah, E. Daraï, and M. Ballester, Contribution of immunohistochemical profile in assessing histological grade of endometrial cancer, Anticancer Res, vol.33, issue.5, pp.2191-2199, 2013.

J. Seror, A. Bats, F. Chamming's, C. Ngo, C. Bensaïd et al.,

J. Brun, A. Cortez, A. Donnadieu, M. Bazot, P. Driguez et al.,

S. A. Törnberg and J. M. Carstensen, Relationship between Quetelet's index and cancer of breast and female genital tract in 47,000 women followed for 25 years, Br J Cancer, vol.69, issue.2, pp.358-61, 1994.

F. Parazzini, L. Vecchia, C. Negri, E. Riboldi, G. L. Surace et al., Diabetes and endometrial cancer: an Italian case-control study, Int J Cancer, vol.81, issue.4, pp.539-581, 1999.

M. Soler, L. Chatenoud, E. Negri, F. Parazzini, S. Franceschi et al., Hypertension and hormone-related neoplasms in women. Hypertens Dallas Tex, 1979.

L. A. Brinton, M. L. Berman, R. Mortel, L. B. Twiggs, R. J. Barrett et al., Reproductive, menstrual, and medical risk factors for endometrial cancer: results from a case-control study, Am J Obstet Gynecol, vol.167, issue.5, pp.1317-1342, 1992.

L. Bernstein, D. Deapen, J. R. Cerhan, S. M. Schwartz, J. Liff et al., Tamoxifen therapy for breast cancer and endometrial cancer risk, J Natl Cancer Inst, vol.91, pp.1654-62, 1999.

K. K. Zorn, T. Bonome, L. Gangi, G. Chandramouli, C. S. Awtrey et al., Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer, Clin Cancer Res Off J Am Assoc Cancer Res, vol.11, issue.18, pp.6422-6452, 2005.

A. K. Win, J. C. Reece, and S. Ryan, Family history and risk of endometrial cancer: a systematic review and meta-analysis, Obstet Gynecol, vol.125, issue.1, pp.89-98, 2015.

L. Remontet, J. Estève, A. Bouvier, P. Grosclaude, G. Launoy et al., Cancer incidence and mortality in France over the period 1978-2000. Rev Dépidémiologie Santé Publique, vol.51, pp.3-30, 2003.
URL : https://hal.archives-ouvertes.fr/hal-00427472

. Inca, Recommandations pour la pratique clinique-Cancer de l'endomètre, 2010.

T. P. Batista, C. Cavalcanti, . Tejo-a-a.-g, and A. Bezerra, Accuracy of preoperative endometrial sampling diagnosis for predicting the final pathology grading in uterine endometrioid carcinoma, Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol, vol.42, issue.9, pp.1367-71, 2016.

R. B. Goldstein, R. L. Bree, C. B. Benson, B. R. Benacerraf, J. D. Bloss et al., Evaluation of the woman with postmenopausal bleeding: Society of Radiologists in Ultrasound-Sponsored Consensus Conference statement, J Ultrasound Med Off J Am Inst Ultrasound Med, vol.20, issue.10, pp.1025-1061, 2001.

T. J. Dubinsky, H. R. Parvey, and N. Maklad, The role of transvaginal sonography and endometrial biopsy in the evaluation of peri-and postmenopausal bleeding, AJR Am J Roentgenol, vol.169, issue.1, pp.145-154, 1997.

J. G. Aalders and G. Thomas, Endometrial cancer-revisiting the importance of pelvic and para aortic lymph nodes, Gynecol Oncol, vol.104, issue.1, pp.222-253, 2007.

E. Petru, H. Lück, G. Stuart, D. Gaffney, D. Millan et al., Gynecologic Cancer Intergroup (GCIG) proposals for changes of the current FIGO staging system, Eur J Obstet Gynecol Reprod Biol, vol.143, issue.2, pp.69-74, 2009.

N. Colombo, C. Creutzberg, F. Amant, T. Bosse, A. González-martín et al., ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-up, Int J Gynecol Cancer Off J Int Gynecol Cancer Soc, 2016.

C. Network, C. Kandoth, and N. Schultz, Integrated genomic characterization of endometrial carcinoma, Nature, vol.497, pp.67-73, 2013.

M. Fung-kee-fung, J. Dodge, L. Elit, H. Lukka, A. Chambers et al., Follow-up after primary therapy for endometrial cancer: a systematic review, Gynecol Oncol, vol.101, issue.3, pp.520-529, 2006.

N. D. Fleming, P. T. Soliman, S. N. Westin, R. Dos-reis, M. Munsell et al., Impact of Lymph Node Ratio and Adjuvant Therapy in Node-Positive Endometrioid Endometrial Cancer, Int J Gynecol Cancer Off J Int Gynecol Cancer Soc, vol.25, issue.8, pp.1437-1481, 2015.

J. Gerdes, U. Schwab, H. Lemke, and H. Stein, Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation, Int J Cancer, vol.31, issue.1, pp.13-20, 1983.

M. Duchrow, C. Schlüter, C. Wohlenberg, H. D. Flad, and J. Gerdes, Molecular characterization of the gene locus of the human cell proliferation-associated nuclear protein defined by monoclonal antibody Ki-67, Cell Prolif, vol.29, issue.1, pp.1-12, 1996.

C. Gerlach, D. Y. Sakkab, T. Scholzen, R. Dassler, M. R. Alison et al., Ki-67 expression during rat liver regeneration after partial hepatectomy. Hepatol Baltim Md, vol.26, pp.573-581, 1997.

S. Bruno and Z. Darzynkiewicz, Cell cycle dependent expression and stability of the nuclear protein detected by Ki-67 antibody in HL-60 cells, Cell Prolif, vol.25, issue.1, pp.31-40, 1992.

S. Du-manoir, P. Guillaud, E. Camus, D. Seigneurin, and G. Brugal, Ki-67 labeling in postmitotic cells defines different Ki-67 pathways within the 2c compartment, Cytometry, vol.12, issue.5, pp.455-63, 1991.

M. Ishihara, H. Mukai, S. Nagai, M. Onozawa, K. Nihei et al., Retrospective analysis of risk factors for central nervous system metastases in operable breast cancer: effects of biologic subtype and Ki67 overexpression on survival, Oncology, vol.84, issue.3, pp.135-175, 2013.

S. W. Sorbye, T. K. Kilvaer, A. Valkov, T. Donnem, E. Smeland et al., Prognostic impact of Jab1, p16, p21, p62, Ki67 and Skp2 in soft tissue sarcomas, PloS One, vol.7, issue.10, p.47068, 2012.

N. Ciancio, M. G. Galasso, R. Campisi, L. Bivona, M. Migliore et al., Prognostic value of p53 and Ki67 expression in fiberoptic bronchial biopsies of patients with non small cell lung cancer, Multidiscip Respir Med, vol.7, issue.1, p.29, 2012.

J. R. Strosberg, A. Nasir, P. Hodul, and L. Kvols, Biology and treatment of metastatic gastrointestinal neuroendocrine tumors. Gastrointest Cancer Res GCR, vol.2, pp.113-138, 2008.

H. B. Salvesen, O. E. Iversen, and L. A. Akslen, Identification of high-risk patients by assessment of nuclear Ki-67 expression in a prospective study of endometrial carcinomas, Clin Cancer Res Off J Am Assoc Cancer Res, vol.4, issue.11, pp.2779-85, 1998.

H. B. Salvesen, O. E. Iversen, and L. A. Akslen, Prognostic significance of angiogenesis and Ki67, p53, and p21 expression: a population-based endometrial carcinoma study, J Clin Oncol Off J Am Soc Clin Oncol, vol.17, issue.5, pp.1382-90, 1999.

K. Konstantinos, S. Marios, M. Anna, K. Nikolaos, P. Efstratios et al., Expression of Ki-67 as proliferation biomarker in imprint smears of endometrial carcinoma, Diagn Cytopathol, vol.41, issue.3, pp.212-219, 2013.

S. Oreskovic, D. Babic, D. Kalafatic, D. Barisic, and L. Beketic-oreskovic, A significance of immunohistochemical determination of steroid receptors, cell proliferation factor Ki-67 and protein p53 in endometrial carcinoma, Gynecol Oncol, vol.93, issue.1, pp.34-40, 2004.

D. Chakravarty, N. Gupta, J. S. Goda, R. Srinivasan, F. D. Patel et al., Steroid receptors, HER2/neu and Ki-67, in endometrioid type of endometrial carcinoma: Correlation with conventional histomorphological features of prognosis, Acta Histochem, vol.112, issue.4, pp.355-63, 2010.

B. K. Tye, MCM proteins in DNA replication, Annu Rev Biochem, vol.68, pp.649-86, 1999.

S. P. Bell and A. Dutta, DNA replication in eukaryotic cells, Annu Rev Biochem, vol.71, pp.333-74, 2002.

J. P. Chong, H. M. Mahbubani, C. Y. Khoo, and J. J. Blow, Purification of an MCM-containing complex as a component of the DNA replication licensing system, Nature, vol.375, issue.6530, pp.418-439, 1995.

Y. Kubota, S. Mimura, S. Nishimoto, H. Takisawa, and H. Nojima, Identification of the yeast MCM3-related protein as a component of Xenopus DNA replication licensing factor, Cell, vol.81, issue.4, pp.601-610, 1995.

T. Tanaka, D. Knapp, and K. Nasmyth, Loading of an Mcm protein onto DNA replication origins is regulated by Cdc6p and CDKs, Cell, vol.90, issue.4, pp.649-60, 1997.

K. Labib, J. A. Tercero, and J. F. Diffley, Uninterrupted MCM2-7 function required for DNA replication fork progression, Science, vol.288, issue.5471, pp.1643-1650, 2000.

J. K. Lee and J. Hurwitz, Isolation and characterization of various complexes of the minichromosome maintenance proteins of Schizosaccharomyces pombe, J Biol Chem, vol.275, issue.25, pp.18871-18879, 2000.

Z. You, Y. Komamura, and Y. Ishimi, Biochemical analysis of the intrinsic Mcm4-Mcm6mcm7 DNA helicase activity, Mol Cell Biol, vol.19, issue.12, pp.8003-8018, 1999.

A. Hiraiwa, M. Fujita, T. Nagasaka, A. Adachi, M. Ohashi et al., Immunolocalization of hCDC47 protein in normal and neoplastic human tissues and its relation to growth, Int J Cancer, vol.74, issue.2, pp.180-184, 1997.

A. Hiraiwa, M. Fujita, A. Adachi, H. Ono, T. Nagasaka et al., Specific distribution patterns of hCDC47 expression in cutaneous diseases, J Cutan Pathol, 1998.

C. B. Harvey, Y. Wang, D. Darmoul, A. Phillips, N. Mantei et al., Characterisation of a human homologue of a yeast cell division cycle gene, MCM6, located adjacent to the 5' end of the lactase gene on chromosome 2q21, FEBS Lett, vol.398, issue.23, pp.135-175, 1996.

D. E. Maccallum and P. A. Hall, The location of pKi67 in the outer dense fibrillary compartment of the nucleolus points to a role in ribosome biogenesis during the cell division cycle, J Pathol, vol.190, issue.5, pp.537-581, 2000.

M. L. Bochman and A. Schwacha, The Mcm complex: unwinding the mechanism of a replicative helicase, Microbiol Mol Biol Rev MMBR, vol.73, issue.4, pp.652-83, 2009.

G. Gauchotte, C. Vigouroux, F. Rech, S. Battaglia-hsu, M. Soudant et al., Expression of minichromosome maintenance MCM6 protein in meningiomas is strongly correlated with histologic grade and clinical outcome, Am J Surg Pathol, vol.36, issue.2, pp.283-91, 2012.

C. Vigouroux, J. Casse, S. Battaglia-hsu, L. Brochin, A. Luc et al., Methyl(R217)HuR and MCM6 are inversely correlated and are prognostic markers in non small cell lung carcinoma, Lung Cancer Amst Neth, vol.89, issue.2, pp.189-96, 2015.

S. S. Li, W. C. Xue, U. S. Khoo, H. Ngan, K. Chan et al., Replicative MCM7 protein as a proliferation marker in endometrial carcinoma: a tissue microarray and clinicopathological analysis, Histopathology, vol.46, issue.3, pp.307-320, 2005.

K. Kato, T. Toki, M. Shimizu, T. Shiozawa, S. Fujii et al., Expression of replication-licensing factors MCM2 and MCM3 in normal, hyperplastic, and carcinomatous endometrium: correlation with expression of Ki-67 and estrogen and progesterone receptors, Int J Gynecol Pathol Off J Int Soc Gynecol Pathol, vol.22, issue.4, pp.334-374, 2003.

N. and N. , The Cancer Genome Atlas (TCGA) Data Portal Use Case Workshop, 2008.

J. I. Sorosky, Endometrial cancer, Obstet Gynecol, vol.111, pp.436-447, 2008.

F. Narducci, E. Lambaudie, and Y. Sonoda, , 2003.

, Gynecol Obstet Fertil, vol.31, pp.581-596

R. A. Soslow, J. P. Bissonnette, and A. Wilton, Clinicopathologic analysis of 187 high-grade endometrial carcinomas of different histologic subtypes: similar outcomes belie distinctive biologic differences, Am J Surg Pathol, vol.31, pp.979-987, 2007.

M. Mengel, R. Von-wasielewski, B. Wiese, T. Rüdiger, H. K. Müller-hermelink et al., Inter-laboratory and inter-observer reproducibility of immunohistochemical assessment of the Ki-67 labelling index in a large multi-centre trial, J Pathol, vol.198, issue.3, pp.292-301, 2002.

R. Verheijen, H. J. Kuijpers, R. Van-driel, J. L. Beck, J. H. Van-dierendonck et al., Ki-67 detects a nuclear matrix-associated proliferation-related antigen. II. Localization in mitotic cells and association with chromosomes, J Cell Sci, vol.92, pp.531-571, 1989.

P. Chatrath, I. S. Scott, L. S. Morris, R. J. Davies, K. Bird et al., Immunohistochemical estimation of cell cycle phase in laryngeal neoplasia, Br J Cancer, vol.95, issue.3, pp.314-335, 2006.

I. S. Scott, L. S. Morris, K. Bird, R. J. Davies, S. L. Vowler et al., A novel immunohistochemical method to estimate cell-cycle phase distribution in archival tissue: implications for the prediction of outcome in colorectal cancer, J Pathol, vol.201, issue.2, pp.187-97, 2003.

S. R. Kingsbury, M. Loddo, T. Fanshawe, E. C. Obermann, A. T. Prevost et al., Repression of DNA replication licensing in quiescence is independent of geminin and may define the cell cycle state of progenitor cells, Exp Cell Res, vol.309, issue.1, pp.56-67, 2005.

K. L. Eward, E. C. Obermann, S. Shreeram, M. Loddo, T. Fanshawe et al., DNA replication licensing in somatic and germ cells, J Cell Sci, vol.117, pp.5875-86, 2004.

A. J. Levine, J. Momand, and C. A. Finlay, The p53 tumour suppressor gene, Nature, vol.351, pp.453-456, 1991.

A. M. Schultheis, L. G. Martelotto, D. Filippo, and M. R. , TP53 Mutational Spectrum in Endometrioid and Serous Endometrial Cancers, Int J Gynecol Pathol Off J Int Soc Gynecol Pathol, vol.35, pp.289-300, 2016.

M. F. Kohler, P. Carney, and R. Dodge, p53 overexpression in advanced-stage endometrial adenocarcinoma, Am J Obstet Gynecol, vol.175, pp.1246-1252, 1996.

P. Kohlberger, G. Gitsch, and A. Loesch, ) p53 protein overexpression in early stage endometrial cancer, Gynecol Oncol, vol.62, pp.213-217, 1996.

S. Ozalp, O. T. Yalcin, and H. M. Tanir, overexpression as a prognostic indicator in endometrial carcinoma, Eur J Gynaecol Oncol, vol.24, pp.275-278, 2003.

M. Kudela, R. Pilka, and M. Lubusky, Prognostic importance of selected molecular immunohistochemical markers and DNA ploidy in endometrial cancer, Eur J Gynaecol Oncol, vol.33, pp.159-163, 2012.

M. Miyaki, M. Konishi, and K. Tanaka, Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer, Nat Genet, vol.17, pp.271-272, 1997.

N. C. Nicolaides, N. Papadopoulos, and B. Liu, Mutations of two PMS homologues in hereditary nonpolyposis colon cancer, Nature, vol.371, pp.75-80, 1994.

H. J. An, K. I. Kim, and J. Y. Kim, Microsatellite instability in endometrioid type endometrial adenocarcinoma is associated with poor prognostic indicators, Am J Surg Pathol, vol.31, pp.846-853, 2007.
DOI : 10.1097/01.pas.0000213423.30880.ac

G. S. Nelson, A. Pink, and S. Lee, MMR deficiency is common in high-grade endometrioid carcinomas and is associated with an unfavorable outcome, Gynecol Oncol, vol.131, pp.309-314, 2013.
DOI : 10.1016/j.ygyno.2013.08.003

M. Ashburner, C. A. Ball, and J. A. Blake, Gene ontology: tool for the unification of biology. The Gene Ontology Consortium, Nat Genet, vol.25, pp.25-29, 2000.

L. S. , ) après déshydratation par des bains successifs d'éthanol à 70°, pp.96-100